McKinsey and Company has agreed to pay $650 million to settle federal probes into boosting sales of OxyContin for Purdue Pharma, an influential consulting company charged with crimes. Former McKinsey senior partner Martin Elling even obstructed justice to destroy company records. This landmark settlement includes considerations like refraining from future opioid-related work and facing closer federal oversight. However, the lack of criminal charges against top executives and limited prison time for wrongdoers raises concerns, fueling calls for more accountability in holding corporate leaders responsible. The DOJ aims to balance the corporate criminal liability and individual prosecution for crimes linked to the opioid crisis.
https://www.npr.org/2024/12/13/nx-s1-5155962/mckinsey-purdue-opioid-prosecution-doj